Literature Highlights November 2021

This highlight deck is comprised of 8 papers

Keywords:

Belimumab, Rituximab, ACR, Antimalarials, Hydroxychloroquine, CV disease, SLE subgroups, Autoantibody status, Productivity with SLE, EULAR, Damage accrual, Economic burden, PROs

LinkedIn